Qiagen
Europe, Limburg, The Netherlands, Venlo
Description
QIAGEN provides technologies and products for preanalytical sample preparation and linked molecular assay solutions.
Investor Profile
Qiagen has backed more than 10 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 40% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States, Germany, Canada.
- Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.
Stage Focus
- Series B (30%)
- Series A (30%)
- Seed (20%)
- Series Unknown (10%)
- Grant (10%)
Country Focus
- United States (50%)
- Germany (40%)
- Canada (10%)
Industry Focus
- Biotechnology
- Health Care
- Health Diagnostics
- Genetics
- Life Science
- Biopharma
- Medical Device
- Precision Medicine
- Oncology
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
